193 related articles for article (PubMed ID: 23032261)
1. B-Myb promotes S-phase independently of its sequence-specific DNA binding activity and interacts with polymerase delta-interacting protein 1 (Pdip1).
Werwein E; Schmedt T; Hoffmann H; Usadel C; Obermann N; Singer JD; Klempnauer KH
Cell Cycle; 2012 Nov; 11(21):4047-58. PubMed ID: 23032261
[TBL] [Abstract][Full Text] [Related]
2. A tumor necrosis factor alpha- and interleukin 6-inducible protein that interacts with the small subunit of DNA polymerase delta and proliferating cell nuclear antigen.
He H; Tan CK; Downey KM; So AG
Proc Natl Acad Sci U S A; 2001 Oct; 98(21):11979-84. PubMed ID: 11593007
[TBL] [Abstract][Full Text] [Related]
3. Characterization of the zinc finger proteins ZMYM2 and ZMYM4 as novel B-MYB binding proteins.
Cibis H; Biyanee A; Dörner W; Mootz HD; Klempnauer KH
Sci Rep; 2020 May; 10(1):8390. PubMed ID: 32439918
[TBL] [Abstract][Full Text] [Related]
4. Interplay with the Mre11-Rad50-Nbs1 complex and phosphorylation by GSK3β implicate human B-Myb in DNA-damage signaling.
Henrich SM; Usadel C; Werwein E; Burdova K; Janscak P; Ferrari S; Hess D; Klempnauer KH
Sci Rep; 2017 Jan; 7():41663. PubMed ID: 28128338
[TBL] [Abstract][Full Text] [Related]
5. Cloning of two rat PDIP1 related genes and their interactions with proliferating cell nuclear antigen.
Zhou J; Hu X; Xiong X; Liu X; Liu Y; Ren K; Jiang T; Hu X; Zhang J
J Exp Zool A Comp Exp Biol; 2005 Mar; 303(3):227-40. PubMed ID: 15726626
[TBL] [Abstract][Full Text] [Related]
6. B-MYB is required for recovery from the DNA damage-induced G2 checkpoint in p53 mutant cells.
Mannefeld M; Klassen E; Gaubatz S
Cancer Res; 2009 May; 69(9):4073-80. PubMed ID: 19383908
[TBL] [Abstract][Full Text] [Related]
7. The transcription factor B-Myb is maintained in an inhibited state in target cells through its interaction with the nuclear corepressors N-CoR and SMRT.
Li X; McDonnell DP
Mol Cell Biol; 2002 Jun; 22(11):3663-73. PubMed ID: 11997503
[TBL] [Abstract][Full Text] [Related]
8. B-Myb is critical for proper DNA duplication during an unperturbed S phase in mouse embryonic stem cells.
Lorvellec M; Dumon S; Maya-Mendoza A; Jackson D; Frampton J; García P
Stem Cells; 2010 Oct; 28(10):1751-9. PubMed ID: 20715180
[TBL] [Abstract][Full Text] [Related]
9. Transactivation mediated by B-Myb is dependent on TAF(II)250.
Bartusel T; Klempnauer KH
Oncogene; 2003 May; 22(19):2932-41. PubMed ID: 12771944
[TBL] [Abstract][Full Text] [Related]
10. A novel role for Gadd45α in base excision repair: modulation of APE1 activity by the direct interaction of Gadd45α with PCNA.
Kim HL; Kim SU; Seo YR
Biochem Biophys Res Commun; 2013 May; 434(2):185-90. PubMed ID: 23485469
[TBL] [Abstract][Full Text] [Related]
11. B-myb promotes S phase and is a downstream target of the negative regulator p107 in human cells.
Sala A; Casella I; Bellon T; Calabretta B; Watson RJ; Peschle C
J Biol Chem; 1996 Apr; 271(16):9363-7. PubMed ID: 8621601
[TBL] [Abstract][Full Text] [Related]
12. Proliferating cell nuclear antigen interacts with the CRL4 ubiquitin ligase subunit CDT2 in DNA synthesis-induced degradation of CDT1.
Leng F; Saxena L; Hoang N; Zhang C; Lee L; Li W; Gong X; Lu F; Sun H; Zhang H
J Biol Chem; 2018 Dec; 293(49):18879-18889. PubMed ID: 30301766
[TBL] [Abstract][Full Text] [Related]
13. ATM protein physically and functionally interacts with proliferating cell nuclear antigen to regulate DNA synthesis.
Gamper AM; Choi S; Matsumoto Y; Banerjee D; Tomkinson AE; Bakkenist CJ
J Biol Chem; 2012 Apr; 287(15):12445-54. PubMed ID: 22362778
[TBL] [Abstract][Full Text] [Related]
14. B-MYB positively regulates serine-threonine kinase receptor-associated protein (STRAP) activity through direct interaction.
Seong HA; Manoharan R; Ha H
J Biol Chem; 2011 Mar; 286(9):7439-56. PubMed ID: 21148321
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of cyclin A/Cdk2 phosphorylation impairs B-Myb transactivation function without affecting interactions with DNA or the CBP coactivator.
Bessa M; Saville MK; Watson RJ
Oncogene; 2001 Jun; 20(26):3376-86. PubMed ID: 11423988
[TBL] [Abstract][Full Text] [Related]
16. Cyclin F suppresses B-Myb activity to promote cell cycle checkpoint control.
Klein DK; Hoffmann S; Ahlskog JK; O'Hanlon K; Quaas M; Larsen BD; Rolland B; Rösner HI; Walter D; Kousholt AN; Menzel T; Lees M; Johansen JV; Rappsilber J; Engeland K; Sørensen CS
Nat Commun; 2015 Jan; 6():5800. PubMed ID: 25557911
[TBL] [Abstract][Full Text] [Related]
17. Temperature-dependent modification and activation of B-MYB: implications for cell survival.
Santilli G; Schwab R; Watson R; Ebert C; Aronow BJ; Sala A
J Biol Chem; 2005 Apr; 280(16):15628-34. PubMed ID: 15618219
[TBL] [Abstract][Full Text] [Related]
18. The cell cycle-regulated B-Myb transcription factor overcomes cyclin-dependent kinase inhibitory activity of p57(KIP2) by interacting with its cyclin-binding domain.
Joaquin M; Watson RJ
J Biol Chem; 2003 Nov; 278(45):44255-64. PubMed ID: 12947099
[TBL] [Abstract][Full Text] [Related]
19. Regulation of the cyclin D1 and cyclin A1 promoters by B-Myb is mediated by Sp1 binding sites.
Bartusel T; Schubert S; Klempnauer KH
Gene; 2005 May; 351():171-80. PubMed ID: 15922873
[TBL] [Abstract][Full Text] [Related]
20. Phosphorylation of B-Myb regulates its transactivation potential and DNA binding.
Johnson TK; Schweppe RE; Septer J; Lewis RE
J Biol Chem; 1999 Dec; 274(51):36741-9. PubMed ID: 10593981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
